Published ahead of print on September 10, 2009, doi:10.1164/rccm.200903-0393OC Am. J. Respir. Crit. Care Med., Volume 180, Number 11, December 2009, 1143-1150 A more recent version of this article appeared on December 1, 2009
Submitted on March 11, 2009 Impaired Vascular Regulation in Patients with Obstructive Sleep Apnea: Effects of CPAP TreatmentKevin J. Reichmuth1,1 Department of Medicine, School of Pharmacy, University of Wisconsin-Madison and the Middleton Veterans Administration Hospital, Madison, Wisconsin, United States, 2 School of Medicine and Public Health and Pharmacy Practice Division, School of Pharmacy, University of Wisconsin-Madison and the Middleton Veterans Administration Hospital, Madison, Wisconsin, United States, 3 Department of Orthopedics and Rehabilitation, School of Pharmacy, University of Wisconsin-Madison and the Middleton Veterans Administration Hospital, Madison, Wisconsin, United States * To whom correspondence should be addressed. E-mail: morgan{at}ortho.wisc.edu.
Rationale. Impaired endothelium-dependent vasodilation has been documented in patients with sleep apnea. This impairment may result in blood flow dysregulation during apnea-induced fluctuations in arterial blood gases. Objective. To test the hypothesis that hypoxic and hypercapnic vasodilation in the forearm and cerebral circulation are impaired in patients with sleep apnea. Methods, Measurements and Main Results. In 20 patients with moderate to severe sleep apnea and 20 control subjects, we measured cerebral flow velocity (transcranial Doppler), forearm blood flow (venous occlusion plethysmography), arterial pressure (automated sphygmomanometry), oxygen saturation (pulse oximetry), ventilation (pneumotachograph), and end-tidal oxygen and carbon dioxide tensions (expired gas analysis) during 3 levels of hypoxia and 2 levels of hypercapnia. A subset of 14 patients was restudied after treatment with continuous positive airway pressure. Cerebral vasodilator responses to hypoxia (-0.65±0.44 vs. -1.02±0.72 [mean±SD] units/% saturation, p=0.03) and hypercapnia (2.01±0.88 vs. 2.57±0.89 units/Torr, p=0.03) were smaller in patients vs. controls. Hypoxic vasodilation in the forearm was also attenuated (-0.05±0.09 vs. -0.10±0.09 units/% saturation, p=0.04). Hypercapnia did not elicit forearm vasodilation in either group. Twelve weeks of continuous positive airway pressure treatment enhanced hypoxic vasodilation in the cerebral circulation (-0.83±0.32 vs. -0.46±0.29 units/% saturation, p=0.01) and forearm (-0.19±0.15 vs. -0.02±0.08 units/% saturation, p=0.003), and hypercapnic vasodilation in the brain showed a trend toward improvement (2.24±0.78 vs. 1.76±0.64 units/Torr, p=0.06). Conclusions. Vasodilator responses to chemical stimuli in the cerebral circulation and the forearm are impaired in many patients with OSA. Some of these impairments can be improved with continuous positive airway pressure. Key words: hypoxia sleep vasodilation cerebral vascular circulation regional blood flow
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||